Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (5299)
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Taub Rebecca — Director
Shares
256
Price
$530.45
Total Value
$135.80K
Shares Held After
457,583
% of Holdings
0.1%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Taub Rebecca — Director
Shares
554
Price
$529.28
Total Value
$293.22K
Shares Held After
457,839
% of Holdings
0.1%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Taub Rebecca — Director
Shares
465
Price
$528.16
Total Value
$245.59K
Shares Held After
458,393
% of Holdings
0.1%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Taub Rebecca — Director
Shares
1,135
Price
$526.95
Total Value
$598.09K
Shares Held After
458,858
% of Holdings
0.2%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Taub Rebecca — Director
Shares
913
Price
$526.05
Total Value
$480.28K
Shares Held After
459,993
% of Holdings
0.2%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Taub Rebecca — Director
Shares
1,489
Price
$525.12
Total Value
$781.90K
Shares Held After
460,906
% of Holdings
0.3%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Taub Rebecca — Director
Shares
1,335
Price
$524.06
Total Value
$699.62K
Shares Held After
462,395
% of Holdings
0.3%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Taub Rebecca — Director
Shares
732
Price
$522.98
Total Value
$382.82K
Shares Held After
463,730
% of Holdings
0.2%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Taub Rebecca — Director
Shares
588
Price
$521.95
Total Value
$306.91K
Shares Held After
464,462
% of Holdings
0.1%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Taub Rebecca — Director
Shares
440
Price
$521.11
Total Value
$229.29K
Shares Held After
465,050
% of Holdings
0.1%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Taub Rebecca — Director
Shares
539
Price
$519.89
Total Value
$280.22K
Shares Held After
465,490
% of Holdings
0.1%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Taub Rebecca — Director
Shares
970
Price
$518.67
Total Value
$503.11K
Shares Held After
466,029
% of Holdings
0.2%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Taub Rebecca — Director
Shares
2,044
Price
$517.84
Total Value
$1.06M
Shares Held After
466,999
% of Holdings
0.4%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Taub Rebecca — Director
Shares
521
Price
$516.81
Total Value
$269.26K
Shares Held After
469,043
% of Holdings
0.1%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Taub Rebecca — Director
Shares
1,578
Price
$515.82
Total Value
$813.97K
Shares Held After
469,564
% of Holdings
0.3%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Taub Rebecca — Director
Shares
937
Price
$514.63
Total Value
$482.21K
Shares Held After
471,142
% of Holdings
0.2%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Taub Rebecca — Director
Shares
960
Price
$513.12
Total Value
$492.59K
Shares Held After
472,079
% of Holdings
0.2%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Taub Rebecca — Director
Shares
960
Price
$512.02
Total Value
$491.54K
Shares Held After
473,039
% of Holdings
0.2%
CG Oncology, Inc. (CGON)
Mulay James — Director
Shares
10,491
Price
$52.99
Total Value
$555.92K
Shares Held After
0
% of Holdings
100.0%
CG Oncology, Inc. (CGON)
Mulay James — Director
Shares
654
Price
$44.16
Total Value
$28.88K
Shares Held After
0
% of Holdings
100.0%
Twist Bioscience Corp (TWST)
Laponis Adam — Chief Financial Officer
Shares
2,738
Price
$35.26
Total Value
$96.54K
Shares Held After
140,031
% of Holdings
1.9%
INSMED Inc (INSM)
Flammer Martina M.D. — Chief Medical Officer
Shares
1,887
Price
$186.19
Total Value
$351.34K
Shares Held After
84,907
% of Holdings
2.2%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
1,855
Price
$78.10
Total Value
$144.88K
Shares Held After
4,518,447
% of Holdings
0.0%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
10,677
Price
$77.46
Total Value
$827.02K
Shares Held After
4,520,302
% of Holdings
0.2%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
6,067
Price
$76.53
Total Value
$464.29K
Shares Held After
4,530,979
% of Holdings
0.1%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
1,401
Price
$75.61
Total Value
$105.93K
Shares Held After
4,537,046
% of Holdings
0.0%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
375
Price
$78.19
Total Value
$29.32K
Shares Held After
715,686
% of Holdings
0.1%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
10,519
Price
$77.61
Total Value
$816.36K
Shares Held After
716,061
% of Holdings
1.4%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
6,955
Price
$76.72
Total Value
$533.57K
Shares Held After
726,580
% of Holdings
0.9%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
2,151
Price
$75.75
Total Value
$162.94K
Shares Held After
733,535
% of Holdings
0.3%
Acumen Pharmaceuticals, Inc. (ABOS)
Meisner Derek M — Chief Legal Officer & Corp Sec
Shares
5,200
Price
$1.76
Total Value
$9.17K
Shares Held After
92,348
% of Holdings
5.3%
Acumen Pharmaceuticals, Inc. (ABOS)
OConnell Daniel Joseph — Director
Shares
12,941
Price
$1.76
Total Value
$22.83K
Shares Held After
598,898
% of Holdings
2.1%
Corvex, Inc. (MOVE)
Leabman Michael Aaron — Director
Shares
783
Price
$7.27
Total Value
$5.69K
Shares Held After
34,937
% of Holdings
2.2%
PTC THERAPEUTICS, INC. (PTCT)
Pauwels Eric — CHIEF BUSINESS OFFICER
Shares
1,722
Price
$77.41
Total Value
$133.30K
Shares Held After
81,165
% of Holdings
2.1%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
107
Price
$79.52
Total Value
$8.51K
Shares Held After
111,312
% of Holdings
0.1%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
686
Price
$78.71
Total Value
$54.00K
Shares Held After
111,419
% of Holdings
0.6%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
1,521
Price
$77.46
Total Value
$117.82K
Shares Held After
112,105
% of Holdings
1.3%
Enliven Therapeutics, Inc. (ELVN)
Lyssikatos Joseph P — CHIEF SCIENTIFIC OFFICER
Shares
50,000
Price
$29.13
Total Value
$1.46M
Shares Held After
765,188
% of Holdings
6.1%
Enliven Therapeutics, Inc. (ELVN)
Lyssikatos Joseph P — CHIEF SCIENTIFIC OFFICER
Shares
41,198
Price
$24.90
Total Value
$1.03M
Shares Held After
815,188
% of Holdings
4.8%
Enliven Therapeutics, Inc. (ELVN)
Heyman Richard A. — Director
Shares
4,285
Price
$25.00
Total Value
$107.13K
Shares Held After
25,107
% of Holdings
14.6%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
24,678
Price
$0.61
Total Value
$15.05K
Shares Held After
2,368,849
% of Holdings
1.0%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
9,075
Price
$6.27
Total Value
$56.90K
Shares Held After
741,292
% of Holdings
1.2%
uniQure N.V. (QURE)
Kaye Jack — Director
Shares
6,390
Price
$27.28
Total Value
$174.32K
Shares Held After
20,439
% of Holdings
23.8%
Ainos, Inc. (AIMD)
Taiwan Carbon Nano Technology Corp — 10% Owner
Shares
431
Price
$1.86
Total Value
$801.66
Shares Held After
1,035,925
% of Holdings
0.0%
Inspire Medical Systems, Inc. (INSP)
Rondoni John — Title: Chief Product and Innovation Officer.
All sale transactions reported herein were made pursuant to a Rule 10b5-1 trading plan dated May 28, 2025.
Shares
109
Price
$100.00
Total Value
$10.90K
Shares Held After
13,797
% of Holdings
0.8%
Fate Therapeutics, Inc. (FATE)
TAHL CINDY — Chief Legal and Compliance Officer
Shares
10,589
Price
$1.06
Total Value
$11.28K
Shares Held After
387,081
% of Holdings
2.7%
Fate Therapeutics, Inc. (FATE)
Valamehr Bahram — Director
Shares
5,190
Price
$1.07
Total Value
$5.56K
Shares Held After
329,708
% of Holdings
1.5%
Zenas BioPharma, Inc. (ZBIO)
MOULDER LEON O JR — Director
Shares
20,000
Price
$16.55
Total Value
$331.00K
Shares Held After
366,155
% of Holdings
5.5%
Warby Parker Inc. (WRBY)
Gilboa David Abraham — Director
Shares
19,906
Price
$29.09
Total Value
$579.07K
Shares Held After
37,247
% of Holdings
34.8%
Edwards Lifesciences Corp (EW)
Lippis Daniel J. — CVP, TAVR
Shares
1,019
Price
$85.70
Total Value
$87.33K
Shares Held After
22,002
% of Holdings
4.4%
Showing 4301–4350 of 5299 transactions (page 87 of 106)